Edgewise Therapeutics, Inc. (EWTX)

NASDAQ: EWTX · Real-Time Price · USD

30.15

+0.07 (0.23%)

At close: Feb 18, 2026, 4:00 PM EST

29.57

-0.58 (-1.92%)

After-hours: Feb 18, 2026, 4:29 PM EST

Edgewise Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	46	41.67	86.1	21.99	15.57	104.92
Short-Term Investments	517.34	428.5	232.3	329.95	265.22	24.18
Cash & Short-Term Investments	563.34	470.17	318.39	351.95	280.79	129.09
Cash Growth	14.37%	47.67%	-9.53%	25.34%	117.51%	445.78%
Prepaid Expenses	10.56	5.31	8.6	5.05	2.98	0.55
Total Current Assets	573.9	475.48	327	357	283.77	129.65
Property, Plant & Equipment	9.57	11.07	12.69	9.85	0.91	0.52
Long-Term Deferred Charges	-	0.26	0.3	0.25	-	0.7
Other Long-Term Assets	-	-	0.05	-	0.55	0.28
Total Assets	583.47	486.82	340.04	367.1	285.23	131.14
Accounts Payable	6.16	5.58	4.03	6.11	3.84	1.58
Accrued Expenses	14.48	17.29	11.77	9.87	6.68	2.31
Current Portion of Leases	1.01	1	0.98	0.61	-	-
Other Current Liabilities	-	-	-	-	-	0.45
Total Current Liabilities	21.65	23.86	16.77	16.59	10.52	4.34
Long-Term Leases	3.17	3.74	4.43	3.8	-	-
Other Long-Term Liabilities	-	-	-	-	0.33	-
Total Liabilities	24.82	27.6	21.21	20.39	10.85	4.34
Common Stock	0.01	0.01	0.01	0.01	0.01	-
Additional Paid-In Capital	1,054	837.36	563.49	492.67	351.85	0.73
Retained Earnings	-496.16	-378.58	-244.76	-144.6	-76.96	-34.15
Comprehensive Income & Other	0.7	0.42	0.1	-1.36	-0.51	-
Total Common Equity	558.65	459.22	318.83	346.72	274.38	-33.42
Shareholders' Equity	558.65	459.22	318.83	346.72	274.38	126.79
Total Liabilities & Equity	583.47	486.82	340.04	367.1	285.23	131.14
Total Debt	4.18	4.74	5.41	4.41	-	-
Net Cash (Debt)	559.16	465.43	312.98	347.54	280.79	129.09
Net Cash Growth	14.56%	48.71%	-9.94%	23.77%	117.51%	445.78%
Net Cash Per Share	5.59	5.04	4.91	6.48	7.48	174.69
Filing Date Shares Outstanding	105.87	95.21	93.11	63.26	49.51	1.01
Total Common Shares Outstanding	105.76	94.84	70.45	63.26	49.5	1.01
Working Capital	552.25	451.62	310.23	340.41	273.25	125.3
Book Value Per Share	5.28	4.84	4.53	5.48	5.54	-33.11
Tangible Book Value	558.65	459.22	318.83	346.72	274.38	-33.42
Tangible Book Value Per Share	5.28	4.84	4.53	5.48	5.54	-33.11
Machinery	4.73	4.54	4.25	2.26	1.61	-
Construction In Progress	-	-	0.08	7.34	-	-
Leasehold Improvements	9.65	9.65	8.73	-	-	-

Updated Nov 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q